Paper3098415
Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
Jordan VC and 2 others. Cancer Res, 1987. Cited by 157 papers, by iCite.
Cite this record
ConductScience Library. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. Papers, record 3098415. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3098415
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Tamoxifen | Major topic |
| Antineoplastic Combined Chemotherapy Protocols | |
| Combined Modality Therapy | |
| Estrogens | |
| Female | |
| Follicle Stimulating Hormone | |
| Humans | |
| Luteinizing Hormone | |
| Lymphatic Metastasis | |
| Menopause | |
| Menstruation | |
| Progesterone | |
| Prolactin | |
| Time Factors |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 14520 | NCI NIH HHS | United States | P01CA014520 | PubMed and NIH | NIH RePORTER |
| P01 20432 | PHS HHS | United States | PubMed | PubMed | |
| P02CA014520 | NIH | NIH RePORTER | |||
| P30CA014520 | NIH | NIH RePORTER | |||
| P60CA014520 | NIH | NIH RePORTER |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 157 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42213241 | Oncofertility in the Age of HER2 Blockade, Immunotherapy, PARP inhibitors, CDK4/6 inhibitors and Endocrine Treatment: Unanswered Questions in Breast Cancer. | Curr Treat Options Oncol | 2026 | https://conductscience.org/library/papers/42213241 | PubMed |
| 35216831 | Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors. | Fertil Steril | 2022 | https://conductscience.org/library/papers/35216831 | PubMed |
| 31897335 | Amenorrhea and Menopause in Patients with Breast Cancer after Chemotherapy. | J Breast Cancer | 2019 | https://conductscience.org/library/papers/31897335 | PubMed |
| 29228681 | Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29228681 | PubMed |
| 27462500 | Prediction of ovarian function in premenopausal breast cancer patients with amenorrhoea after chemotherapy: a simple clinical score. | Springerplus | 2016 | https://conductscience.org/library/papers/27462500 | PubMed |
| 25269699 | Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/25269699 | PubMed |
| 25258390 | Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/25258390 | PubMed |
| 25084324 | From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs). | Steroids | 2014 | https://conductscience.org/library/papers/25084324 | PubMed |
| 24805199 | Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells. | J Med Chem | 2014 | https://conductscience.org/library/papers/24805199 | PubMed |
| 24504100 | Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study. | Osteoporos Int | 2014 | https://conductscience.org/library/papers/24504100 | PubMed |
| 23840510 | Tamoxifen and ovarian function. | PLoS One | 2013 | https://conductscience.org/library/papers/23840510 | PubMed |
| 23150063 | Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. | Cancer Epidemiol Biomarkers Prev | 2013 | https://conductscience.org/library/papers/23150063 | PubMed |
| 19918920 | Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. | Cancer | 2010 | https://conductscience.org/library/papers/19918920 | PubMed |
| 19749156 | G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. | Mol Endocrinol | 2009 | https://conductscience.org/library/papers/19749156 | PubMed |
| 18427357 | Body size affects measures of ovarian reserve in late reproductive age women. | Menopause | 2008 | https://conductscience.org/library/papers/18427357 | PubMed |
| 14709804 | Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys. | Endocrine | 2003 | https://conductscience.org/library/papers/14709804 | PubMed |
| 11122897 | Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer. | Curr Oncol Rep | 2000 | https://conductscience.org/library/papers/11122897 | PubMed |
| 10718636 | Regulation of heat shock protein 72 kDa and 90 kDa in human breast cancer MDA-MB-231 cells. | Mol Cell Biochem | 2000 | https://conductscience.org/library/papers/10718636 | PubMed |
| 10665480 | Antiestrogens--tamoxifen, SERMs and beyond. | Invest New Drugs | 1999 | https://conductscience.org/library/papers/10665480 | PubMed |
| 10396232 | Gynaecological effects of tamoxifen. | J Clin Pathol | 1999 | https://conductscience.org/library/papers/10396232 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PRL | 5617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3098415
GET https://conductscience.org/api/papers/v1/3098415/cited_by?page=2